BusinessLegalPipelineResearchEventsProducts
Browse All Stories »
FEATURED
Patients uncontrolled with cyclosporine A (CsA 0.05%)

Patients uncontrolled with cyclosporine A (CsA 0.05%)

Learn more about an alternative cyclosporine therapy for dry eye patients.

Earn FREE CE 24/7 with Courses by Eyes On Eyecare

Check it out

Explore premium-quality, bite-sized courses featuring leading experts like Cecelia Koetting, OD, FAAO, and Cory Lappin, OD, MS, FAAO, and continuing education covering topics from ocular rosacea treatments to retinal disease.

TRENDING
Videos
Barti introduces AI transcription tech for optometrists
Barti introduces AI transcription tech for optometrists
Rinsada's irrigating eyelid retractor targets ocular surface restoration
Rinsada's irrigating eyelid retractor targets ocular surface restoration
Keratoconus eye drop regenerates lost collagen in the eye
Keratoconus eye drop regenerates lost collagen in the eye
Eye safety tips you need to know ahead of the solar eclipse
Eye safety tips you need to know ahead of the solar eclipse
Watch More
Business
Ocular Therapeutix announces executive chairman as new CEO
Ocular Therapeutix announces executive chairman as new CEO
ASCRS names Vance Thompson, MD, as president
ASCRS names Vance Thompson, MD, as president
Global Myopia Awareness Coalition names 2024 Board of Directors
Global Myopia Awareness Coalition names 2024 Board of Directors
Lenz Therapeutics merges with Graphite Bio
Lenz Therapeutics merges with Graphite Bio
Research
Scientists establish AH protein database for vision loss research
Scientists establish AH protein database for vision loss research
CSC may get a protected boost from spironolactone
CSC may get a protected boost from spironolactone
Study: Artificial tears disrupt ocular surface inflammation cycle
Study: Artificial tears disrupt ocular surface inflammation cycle
Orbis and FundamentalVR roll out VR cataract surgery training
Orbis and FundamentalVR roll out VR cataract surgery training
Pipeline
Ocuphire enrolls first patient in LYNX-2 phase 3 study for phentolamine
Ocuphire enrolls first patient in LYNX-2 phase 3 study for phentolamine
Pantheon Vision closes on $1.8M to advance bioengineered corneal implants
Pantheon Vision closes on $1.8M to advance bioengineered corneal implants
Kiora Pharma secures IRD grant for late-stage RP trial
Kiora Pharma secures IRD grant for late-stage RP trial
Oculis releases positive phase 3 data from OPTIMIZE-1 trial for post-op inflammation and pain
Oculis releases positive phase 3 data from OPTIMIZE-1 trial for post-op inflammation and pain
Products
Patients uncontrolled with cyclosporine A (CsA 0.05%)
Patients uncontrolled with cyclosporine A (CsA 0.05%)
Artificial vision system offers groundbreaking results for blindness
Artificial vision system offers groundbreaking results for blindness
Oasis launches SOFT PLUG Extended Duration 180-T Tapered Plug
Oasis launches SOFT PLUG Extended Duration 180-T Tapered Plug
iHealthScreen receives US patent for iPredict glaucoma detection model
iHealthScreen receives US patent for iPredict glaucoma detection model
Legal
The Vision Council launches online regulatory monitoring service for optical industry
The Vision Council launches online regulatory monitoring service for optical industry
Regeneron faces DOJ complaint in alleged Medicare overcharge of Eylea
Regeneron faces DOJ complaint in alleged Medicare overcharge of Eylea
Florida ODs kill yet another not-a-doctor bill
Florida ODs kill yet another not-a-doctor bill
AAO weighs in on Congress passing Medicare Physician Payment adjustment
AAO weighs in on Congress passing Medicare Physician Payment adjustment
Archives
Hello 2023 — Weekly Glance
Hello 2023 — Weekly Glance
Can we treat uveitis without steroids? — Weekly Glance
Can we treat uveitis without steroids? — Weekly Glance
Can I have one dilation drop instead of two? — Weekly Glance
Can I have one dilation drop instead of two? — Weekly Glance
Are those dilation reversal drops available yet? — Weekly Glance
Are those dilation reversal drops available yet? — Weekly Glance
Events
CooperVision and AOA launch The Myopia Collective
CooperVision and AOA launch The Myopia Collective
AAPOS names VP as next president
AAPOS names VP as next president
BostonSight adds new immersive training to FitAcademy program
BostonSight adds new immersive training to FitAcademy program
Eye safety tips you need to know ahead of the solar eclipse
Eye safety tips you need to know ahead of the solar eclipse
Browse All Stories »